NEAL KLEIMAN

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Desai VR, Lee JJ, Sample T, Kleiman NS, Lumsden A, Britz GW. First in Man Pilot Feasibility Study in Extracranial Carotid Robotic-Assisted Endovascular Intervention. Neurosurgery. 2021 Feb 16; 88(3):506-514. PMID: 33313923.
      Citations:    Fields:    
    2. Gupta T, Joseph DT, Goel SS, Kleiman NS. Predicting and Measuring Mortality Risk After Transcatheter Aortic Valve Replacement. Expert Rev Cardiovasc Ther. 2021 Feb 09. PMID: 33560150.
      Citations:    Fields:    
    3. Kleiman NS. Is This a Good Time to Revisit the Tropics?: Platelet Function Testing in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2021 Feb 22; 14(4):428-430. PMID: 33516695.
      Citations:    Fields:    
    4. Lador A, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS, Valderrábano M. Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021 Jan 19. PMID: 33482387.
      Citations:    Fields:    
    5. Kleiman NS, Welt FGP, Truesdell AG, Sherwood M, Kadavath S, Shah PB, Klein LW, Hogan S, Kavinsky C, Rab T. Should Interventional Cardiologists Super-Subspecialize?: Moving From Patient Selection to Operator Selection. JACC Cardiovasc Interv. 2021 Jan 11; 14(1):97-100. PMID: 33413871.
      Citations:    Fields:    
    6. Tayal B, Debs D, Nabi F, Malahfji M, Little SH, Reardon M, Zoghbi W, Kleiman N, Shah DJ. Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure. JACC Cardiovasc Imaging. 2020 Dec 10. PMID: 33341417.
      Citations:    Fields:    
    7. Wyler von Ballmoos MC, Reardon MJ, Williams MR, Mangi AA, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Oh JK, Qiao H, Forrest JK. Three-year outcomes with a contemporary self-expanding transcatheter valve from the Evolut PRO US Clinical Study. Cardiovasc Revasc Med. 2020 Nov 10. PMID: 33199247.
      Citations:    Fields:    
    8. Valderrábano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, DeLurgio D, Athill CA, Ellenbogen KA, Natale A, Koneru J, Dave AS, Giorgberidze I, Afshar H, Guthrie ML, Bunge R, Morillo CA, Kleiman NS. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020 10 27; 324(16):1620-1628. PMID: 33107945.
      Citations:    Fields:    Translation:Humans
    9. Elbadawi A, Elgendy IY, Megaly M, Ugwu J, Shahin HI, Al-Azizi K, Garcia S, Abbott JD, Gafoor S, Kleiman NS, Goel SS. Trends and Outcomes of Transcatheter Aortic Valve Implantation Among Solid Organ Transplant Recipients. Am J Cardiol. 2021 01 01; 138:122-124. PMID: 33038308.
      Citations:    Fields:    Translation:Humans
    10. Zhan Y, Debs D, Khan MA, Nguyen DT, Graviss EA, Khalaf S, Little SH, Reardon MJ, Nagueh S, Quiñones MA, Kleiman N, Zoghbi WA, Shah DJ. Natural History of Functional Tricuspid Regurgitation Quantified by Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2020 09 15; 76(11):1291-1301. PMID: 32912443.
      Citations:    Fields:    Translation:Humans
    11. Kleiman NS. Cautionary Tale or Exploratory Trek - Predicting Mortality Using the DAPT Score. Cardiovasc Revasc Med. 2020 Dec; 21(12):1515-1516. PMID: 33028506.
      Citations:    Fields:    
    12. Goel SS, Kleiman NS, Zoghbi WA, Reardon MJ, Kapadia SR. Renin-Angiotensin System Blockade in Aortic Stenosis: Implications Before and After Aortic Valve Replacement. J Am Heart Assoc. 2020 09 15; 9(18):e016911. PMID: 32893727.
      Citations: 2     Fields:    
    13. Goel K, O'Leary JM, Barker CM, Levack M, Rajagopal V, Makkar RR, Bajwa T, Kleiman N, Linke A, Kereiakes DJ, Waksman R, Allocco DJ, Rizik DG, Reardon MJ, Lindman BR. Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2020 09; 9(17):e017075. PMID: 32856530.
      Citations: 1     Fields:    
    14. Yakubov SJ, Van Mieghem NM, Reardon MJ, Serruys PW, Gada H, Mumtaz M, Deeb GM, Kodali S, George I, Windecker S, Kleiman N, Chetcuti SJ, Sanchez C, Dauerman HL, Li S, Popma JJ. Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial). Am J Cardiol. 2020 09 15; 131:82-90. PMID: 32723555.
      Citations:    Fields:    Translation:Humans
    15. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheter Cardiovasc Interv. 2020 09 01; 96(3):659-663. PMID: 32251546.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    16. Chitturi KR, Faza NN, Little SH, Kleiman NS, Reardon MJ, Goel SS. Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic. Cardiovasc Revasc Med. 2020 08; 21(8):950-953. PMID: 32473912.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    17. Goel SS, Greenbaum AB, Patel A, Little SH, Parikh R, Wyler von Ballmoos MC, Lumsden AB, Reardon MJ, Kleiman NS. Role of Teleproctoring in Challenging and Innovative Structural Interventions Amid the COVID-19 Pandemic and Beyond. JACC Cardiovasc Interv. 2020 08 24; 13(16):1945-1948. PMID: 32819483.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    18. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020 06 22; 13(12):1484-1488. PMID: 32250751.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    19. Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, Mumtaz M, Ramlawi B, Kleiman NS, Sorajja P, Askew J, Meduri CU, Kauten J, Melnitchouk S, Inglessis I, Huang J, Boulware M, Reardon MJ. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study. J Am Coll Cardiol. 2020 05 19; 75(19):2430-2442. PMID: 32234463.
      Citations: 1     Fields:    Translation:Humans
    20. Reardon MJ, Kleiman NS. Commentary: Pacemaker requirement with rapid-deployment aortic valves. J Thorac Cardiovasc Surg. 2020 Feb 14. PMID: 32164946.
      Citations:    Fields:    
    21. Van Mieghem NM, Popma JJ, Deeb GM, Yakubov SJ, Serruys PW, Windecker S, Søndergaard L, Mumtaz M, Gada H, Chetcuti S, Kleiman NS, Kodali S, George I, Teefy P, Kiaii B, Oh JK, Kappetein AP, Chang Y, Mugglin AS, Reardon MJ. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC Cardiovasc Interv. 2020 02 10; 13(3):323-331. PMID: 32029248.
      Citations:    Fields:    Translation:Humans
    22. Faroux L, Muntané-Carol G, Urena M, Nombela-Franco L, Amat-Santos I, Kleiman N, Munoz-Garcia A, Atienza F, Serra V, Deyell MW, Veiga-Fernandez G, Masson JB, Canadas-Godoy V, Himbert D, Fischer Q, Castrodeza J, Elizaga J, Pascual JF, Webb JG, de la Torre JM, Asmarats L, Pelletier-Beaumont E, Alméndarez M, Couture T, Philippon F, Rodes-Cabau J. Late Electrocardiographic Changes in Patients With New-Onset Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 03 01; 125(5):795-802. PMID: 31889524.
      Citations: 1     Fields:    Translation:Humans
    23. Panesar SS, Volpi JJ, Lumsden A, Desai V, Kleiman NS, Sample TL, Elkins E, Britz GW. Telerobotic stroke intervention: a novel solution to the care dissemination dilemma. J Neurosurg. 2019 Nov 29; 132(3):971-978. PMID: 31783366.
      Citations:    Fields:    
    24. Garcia-Garcia HM, McFadden EP, von Birgelen C, Rademaker-Havinga T, Spitzer E, Kleiman NS, Cohen DJ, Kennedy KF, Camenzind E, Mauri L, Steg PG, Wijns W, Silber S, van Es GA, Serruys PW, Windecker S, Cutlip D, Vranckx P. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 10 14; 12(19):1954-1962. PMID: 31601389.
      Citations: 2     Fields:    Translation:HumansCells
    25. Burke DA, Kundi H, Almonacid A, O'Neill W, Moses J, Kleiman N, Dixon S, Palacios I, Guzman LA, Ohman EM, Popma JJ, Pinto DS. The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. JACC Cardiovasc Interv. 2019 10 14; 12(19):1985-1987. PMID: 31601396.
      Citations:    Fields:    Translation:Humans
    26. Dauerman HL, Deeb GM, O'Hair DP, Waksman R, Yakubov SJ, Kleiman NS, Chetcuti SJ, Hermiller JB, Bajwa T, Khabbaz K, de Marchena E, Salerno T, Dries-Devlin JL, Li S, Popma JJ, Reardon MJ. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses. Circ Cardiovasc Interv. 2019 10; 12(10):e008155. PMID: 31607151.
      Citations: 2     Fields:    Translation:Humans
    27. Khalid U, Bandeali S, Jones PG, Virani SS, Hira R, Hamzeh I, Chan PS, Kleiman NS, Lakkis N, Alam M. Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812. PMID: 31668345.
      Citations:    Fields:    Translation:Humans
    28. Pineda AM, Harrison JK, Kleiman NS, Rihal CS, Kodali SK, Kirtane AJ, Leon MB, Sherwood MW, Manandhar P, Vemulapalli S, Beohar N. Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2019 09 23; 12(18):1751-1764. PMID: 31537276.
      Citations:    Fields:    Translation:Humans
    29. Kalra A, Raza S, Hussain M, Shorbaji K, Delozier S, Deo SV, Khera S, Kleiman NS, Reardon MJ, Kolte D, Gupta T, Mustafa R, Bhatt DL, Sabik JF. Aortic Valve Replacement in Bioprosthetic Failure: Insights From The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2020 11; 110(5):1637-1642. PMID: 31557477.
      Citations: 1     Fields:    Translation:Humans
    30. Elbadawi A, Naqvi SY, Saad M, Elgendy IY, Mahmoud AA, Zainal A, Megaly M, Almahmoud MF, Altaweel A, Kleiman N, Abbott JD. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609. PMID: 31757744.
      Citations:    Fields:    Translation:Humans
    31. Khan MR, Kayani WT, Ahmad W, Manan M, Hira RS, Hamzeh I, Jneid H, Virani SS, Kleiman N, Lakkis N, Alam M. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clin Cardiol. 2019 Nov; 42(11):1071-1078. PMID: 31486094.
      Citations:    Fields:    Translation:Humans
    32. Reardon MJ, Heijmen RH, Van Mieghem NM, Williams MR, Yakubov SJ, Watson D, Kleiman NS, Conte J, Chawla A, Hockmuth D, Petrossian G, Robinson N, Kappetein AP, Li S, Popma JJ. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial. JAMA Cardiol. 2019 08 01; 4(8):810-814. PMID: 31215985.
      Citations:    Fields:    Translation:Humans
    33. Wyler von Ballmoos MC, Barker CM, Kothapalli PR, Kleiman NS, Reardon MJ. Surgical Bailout for Left Ventricular Outflow Tract Obstruction Following a Complicated Mitral Valve-in-Valve Procedure. Cardiovasc Revasc Med. 2020 Nov; 21(11):1343-1347. PMID: 31474548.
      Citations:    Fields:    
    34. Huded CP, Tuzcu EM, Krishnaswamy A, Mick SL, Kleiman NS, Svensson LG, Carroll J, Thourani VH, Kirtane AJ, Manandhar P, Kosinski AS, Vemulapalli S, Kapadia SR. Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. JAMA. 2019 06 18; 321(23):2306-2315. PMID: 31211345.
      Citations: 6     Fields:    Translation:Humans
    35. Valderrábano M, Peterson LE, Bunge R, Prystash M, Dave AS, Nagueh S, Kleiman NS. Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial design. Am Heart J. 2019 09; 215:52-61. PMID: 31279972.
      Citations: 1     Fields:    Translation:Humans
    36. Beg F, Dadu RT, Reardon MJ, Little SH, Kleiman NS, Barker CM. Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve. Methodist Debakey Cardiovasc J. 2019 Apr-Jun; 15(2):149-151. PMID: 31384379.
      Citations:    Fields:    Translation:Humans
    37. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 05 02; 380(18):1706-1715. PMID: 30883053.
      Citations: 169     Fields:    Translation:Humans
    38. Khera S, Villablanca PA, Kolte D, Gupta T, Hasan Khan M, Velagapudi P, Kalra A, Kleiman N, Aronow HD, Abbott JD, Rosenfield K, Drachman DE, Bangalore S, Bhatt DL, Naidu SS. Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis. Cardiol Rev. 2018 Nov/Dec; 26(6):277-286. PMID: 30157064.
      Citations:    Fields:    Translation:Humans
    39. Durko AP, Reardon MJ, Kleiman NS, Popma JJ, Van Mieghem NM, Gleason TG, Bajwa T, O'Hair D, Brown DL, Ryan WH, Chang Y, De Leon SD, Kappetein AP. Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients. J Am Coll Cardiol. 2018 10 30; 72(18):2109-2119. PMID: 30360820.
      Citations: 1     Fields:    Translation:Humans
    40. Pineda AM, Kevin Harrison J, Kleiman NS, Reardon MJ, Conte JV, O'Hair DP, Chetcuti SJ, Huang J, Yakubov SJ, Popma JJ, Beohar N. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement. Catheter Cardiovasc Interv. 2019 03 01; 93(4):740-748. PMID: 30341970.
      Citations: 1     Fields:    Translation:Humans
    41. Kleiman NS. Too Thick to Cut With SISRs. Circ Cardiovasc Interv. 2018 10; 11(10):e007365. PMID: 30354643.
      Citations:    Fields:    
    42. Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol. 2018 12 04; 72(22):2687-2696. PMID: 30249462.
      Citations: 23     Fields:    Translation:Humans
    43. Dadu RT, Xu J, Rehman H, von Ballmoos MW, Barker CM, Reyes M, Ramchandani M, Reul RM, Reardon MJ, Kleiman NS. Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019 01 01; 93(1):149-155. PMID: 30218488.
      Citations:    Fields:    Translation:Humans
    44. Kleiman NS, Reardon MJ. Does Orientation Matter? JACC Cardiovasc Interv. 2018 09 10; 11(17):1744-1745. PMID: 30121277.
      Citations:    Fields:    Translation:Humans
    45. Hannawi B, Hannawi Y, Kleiman NS. Reticulated Platelets: Changing Focus from Basics to Outcomes. Thromb Haemost. 2018 Sep; 118(9):1517-1527. PMID: 30103247.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    46. Ibrahim H, Rondina MT, Kleiman NS. Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era. Thromb Res. 2018 10; 170:20-27. PMID: 30092557.
      Citations: 1     Fields:    Translation:Humans
    47. Rodés-Cabau J, Urena M, Nombela-Franco L, Amat-Santos I, Kleiman N, Munoz-Garcia A, Atienza F, Serra V, Deyell MW, Veiga-Fernandez G, Masson JB, Canadas-Godoy V, Himbert D, Castrodeza J, Elizaga J, Francisco Pascual J, Webb JG, de la Torre JM, Asmarats L, Pelletier-Beaumont E, Philippon F. Arrhythmic Burden as Determined by Ambulatory Continuous Cardiac Monitoring in Patients With New-Onset Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement: The MARE Study. JACC Cardiovasc Interv. 2018 08 13; 11(15):1495-1505. PMID: 30031719.
      Citations: 8     Fields:    Translation:Humans
    48. Rehman H, Kleiman NS, Kalra A. Transcatheter valvular interventions in 2017: some things old, some things new! Curr Opin Cardiol. 2018 07; 33(4):363-368. PMID: 29697545.
      Citations:    Fields:    Translation:Humans
    49. Kleiman NS. Never So Simple: Bedside Measurement of Platelet Reactivity and the Risk of Stroke After Coronary Stenting. JACC Cardiovasc Interv. 2018 07 09; 11(13):1287-1289. PMID: 29908970.
      Citations:    Fields:    Translation:HumansCells
    50. Kleiman NS. Delayed Coronary Obstruction After TAVR: A Call for Vigilance. J Am Coll Cardiol. 2018 04 10; 71(14):1525-1527. PMID: 29622158.
      Citations: 2     Fields:    Translation:Humans
    51. Gupta T, Khera S, Kolte D, Goel K, Kalra A, Villablanca PA, Aronow HD, Abbott JD, Fonarow GC, Taub CC, Kleiman NS, Weisz G, Inglessis I, Elmariah S, Rihal CS, Garcia MJ, Bhatt DL. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes. Circ Cardiovasc Interv. 2018 04; 11(4):e006179. PMID: 29643130.
      Citations: 8     Fields:    Translation:Humans
    52. Kalra A, Avenatti E, Chinnadurai P, Reardon MJ, Kleiman NS, Little SH, Barker CM. Very Late Migration of Balloon-Expandable Transcatheter Aortic Valve. J Invasive Cardiol. 2018 Apr; 30(4):E28-E30. PMID: 29610447.
      Citations:    Fields:    Translation:Humans
    53. Marian AJ, Tan Y, Li L, Chang J, Syrris P, Hessabi M, Rahbar MH, Willerson JT, Cheong BY, Liu CY, Kleiman NS, Bluemke DA, Nagueh SF. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study. Circ Res. 2018 04 13; 122(8):1109-1118. PMID: 29540445.
      Citations: 4     Fields:    Translation:Humans
    54. Kleiman NS. Bleeding Edge Technology: Retroperitoneal Hemorrhage and Its Implications for Transradial Access. Circ Cardiovasc Interv. 2018 02; 11(2):e006320. PMID: 29445003.
      Citations:    Fields:    Translation:Humans
    55. Little SH, Popma JJ, Kleiman NS, Deeb GM, Gleason TG, Yakubov SJ, Checuti S, O'Hair D, Bajwa T, Mumtaz M, Maini B, Hartman A, Katz S, Robinson N, Petrossian G, Heiser J, Merhi W, Moore BJ, Li S, Adams DH, Reardon MJ. Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery. J Thorac Cardiovasc Surg. 2018 05; 155(5):1991-1999. PMID: 29429630.
      Citations: 1     Fields:    Translation:Humans
    56. Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC Cardiovasc Interv. 2018 01 22; 11(2):160-168. PMID: 29348010.
      Citations: 9     Fields:    Translation:Humans
    57. Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchétché D, Rovin JD, Buchbinder M, Meredith IT, Götberg M, Bjursten H, Meduri C, Salinger MH, Allocco DJ, Dawkins KD. Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial. JAMA. 2018 01 02; 319(1):27-37. PMID: 29297076.
      Citations: 17     Fields:    Translation:Humans
    58. Kleiman N. Stenting: the Latest Frontier in Percutaneous Intervention. Methodist Debakey Cardiovasc J. 2018 Jan-Mar; 14(1):5-6. PMID: 29623166.
      Citations:    Fields:    Translation:Humans
    59. Aggarwal B, Aman W, Jeroudi O, Kleiman NS. Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention. Methodist Debakey Cardiovasc J. 2018 Jan-Mar; 14(1):23-31. PMID: 29623169.
      Citations: 1     Fields:    Translation:Humans
    60. Bapat V, Rajagopal V, Meduri C, Farivar RS, Walton A, Duffy SJ, Gooley R, Almeida A, Reardon MJ, Kleiman NS, Spargias K, Pattakos S, Ng MK, Wilson M, Adams DH, Leon M, Mack MJ, Chenoweth S, Sorajja P. Early Experience With New Transcatheter Mitral Valve Replacement. J Am Coll Cardiol. 2018 01 02; 71(1):12-21. PMID: 29102689.
      Citations: 25     Fields:    Translation:Humans
    61. Ibrahim H, Kleiman NS. Platelet pathophysiology, pharmacology, and function in coronary artery disease. Coron Artery Dis. 2017 Nov; 28(7):614-623. PMID: 28644213.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    62. Saad M, Nairooz R, Pothineni NVK, Almomani A, Kovelamudi S, Sardar P, Katz M, Abdel-Wahab M, Bangalore S, Kleiman NS, Block PC, Abbott JD. Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis. JACC Cardiovasc Interv. 2018 01 08; 11(1):24-35. PMID: 29055767.
      Citations: 7     Fields:    Translation:Humans
    63. Kleiman NS. In Touch But Out of Time: Aggressive Hospital Discharge and Readmissions After Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2017 08 21; 6(8). PMID: 28862967.
      Citations:    Fields:    Translation:Humans
    64. Gupta T, Kalra A, Kolte D, Khera S, Villablanca PA, Goel K, Bortnick AE, Aronow WS, Panza JA, Kleiman NS, Abbott JD, Slovut DP, Taub CC, Fonarow GC, Reardon MJ, Rihal CS, Garcia MJ, Bhatt DL. Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States. Am J Cardiol. 2017 Nov 15; 120(10):1869-1876. PMID: 28865889.
      Citations: 4     Fields:    Translation:Humans
    65. Hira RS, Vemulapalli S, Li Z, McCabe JM, Rumsfeld JS, Kapadia SR, Alam M, Jneid H, Don C, Reisman M, Virani SS, Kleiman NS. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 08 01; 2(8):846-854. PMID: 28636718.
      Citations: 8     Fields:    Translation:Humans
    66. Khera S, Kolte D, Gupta T, Goldsweig A, Velagapudi P, Kalra A, Tang GHL, Aronow WS, Fonarow GC, Bhatt DL, Aronow HD, Kleiman NS, Reardon M, Gordon PC, Sharaf B, Abbott JD. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2017 07 01; 2(7):732-741. PMID: 28494061.
      Citations: 9     Fields:    Translation:Humans
    67. Sarkar K, Reardon MJ, Little SH, Barker CM, Kleiman NS. Transcatheter Mitral Valve Replacement for Native and Failed Bioprosthetic Mitral Valves. Methodist Debakey Cardiovasc J. 2017 Jul-Sep; 13(3):142-151. PMID: 29743999.
      Citations: 1     Fields:    Translation:Humans
    68. Kalra A, Uberoi AS, Latib A, Khera S, Little SH, Bhatt DL, Reardon MJ, Kleiman NS, Barker CM. Emerging Transcatheter Options for Tricuspid Regurgitation. Methodist Debakey Cardiovasc J. 2017 Jul-Sep; 13(3):120-125. PMID: 29743996.
      Citations: 1     Fields:    Translation:Humans
    69. Kalra A, Reyes M, Yang EY, Little SH, Nabi F, Barker CM, Ramchandani M, Reul RM, Reardon MJ, Kleiman NS. Transcatheter Aortic Valve Replacement for Perceval Sutureless Aortic Valve Failure. J Invasive Cardiol. 2017 Jun; 29(6):E65-E66. PMID: 28570238.
      Citations: 1     Fields:    Translation:Humans
    70. Kalra A, Rehman H, Ramchandani M, Barker CM, Lawrie GM, Reul RM, Reardon MJ, Kleiman NS. Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center. J Thorac Cardiovasc Surg. 2017 10; 154(4):1235-1240. PMID: 28610762.
      Citations: 4     Fields:    Translation:Humans
    71. Deeb GM, Chetcuti SJ, Reardon MJ, Patel HJ, Grossman PM, Schreiber T, Forrest JK, Bajwa TK, O'Hair DP, Petrossian G, Robinson N, Katz S, Hartman A, Dauerman HL, Schmoker J, Khabbaz K, Watson DR, Yakubov SJ, Oh JK, Li S, Kleiman NS, Adams DH, Popma JJ. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC Cardiovasc Interv. 2017 05 22; 10(10):1034-1044. PMID: 28521921.
      Citations: 9     Fields:    Translation:Humans
    72. Sotomi Y, Onuma Y, Collet C, Tenekecioglu E, Virmani R, Kleiman NS, Serruys PW. Bioresorbable Scaffold: The Emerging Reality and Future Directions. Circ Res. 2017 Apr 14; 120(8):1341-1352. PMID: 28408454.
      Citations: 5     Fields:    Translation:Humans
    73. Kleiman NS, Kleiman NJ. At Arm's Length: Radiation Safety During Radial Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 05 23; 69(20):2538-2541. PMID: 28330795.
      Citations:    Fields:    Translation:HumansPHPublic Health
    74. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 04 06; 376(14):1321-1331. PMID: 28304219.
      Citations: 275     Fields:    Translation:Humans
    75. Kalra A, Rehman H, Khera S, Thyagarajan B, Bhatt DL, Kleiman NS, Yeh RW. New-Generation Coronary Stents: Current Data and Future Directions. Curr Atheroscler Rep. 2017 Mar; 19(3):14. PMID: 28220461.
      Citations: 8     Fields:    Translation:Humans
    76. O'Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G. One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. Ann Thorac Surg. 2017 May; 103(5):1392-1398. PMID: 28242075.
      Citations:    Fields:    Translation:Humans
    77. Gaudiani V, Deeb GM, Popma JJ, Adams DH, Gleason TG, Conte JV, Zorn GL, Hermiller JB, Chetcuti S, Mumtaz M, Yakubov SJ, Kleiman NS, Huang J, Reardon MJ. Causes of death from the randomized CoreValve US Pivotal High-Risk Trial. J Thorac Cardiovasc Surg. 2017 06; 153(6):1293-1301.e1. PMID: 28249691.
      Citations:    Fields:    Translation:HumansAnimals
    78. Kalra A, Reardon MJ, Kleiman NS. Optimizing Management of Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: The Importance of Distinguishing Pre-Existing From New Onset Atrial Fibrillation. JACC Cardiovasc Interv. 2017 01 09; 10(1):101-103. PMID: 28057276.
      Citations:    Fields:    Translation:Humans
    79. Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Arnold SV, Kleiman NS, Spertus JA. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. Cardiovasc Revasc Med. 2017 Apr - May; 18(3):169-176. PMID: 28041858.
      Citations:    Fields:    Translation:Humans
    80. Reardon MJ, Kleiman NS, Adams DH, Yakubov SJ, Coselli JS, Deeb GM, O'Hair D, Gleason TG, Lee JS, Hermiller JB, Chetcuti S, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Huang J, Popma JJ. Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. JAMA Cardiol. 2016 11 01; 1(8):945-949. PMID: 27541162.
      Citations: 7     Fields:    Translation:Humans
    81. Kleiman NS, Reardon MJ. Von Willebrand factor, paravalvular leak, and a new vista for TAVR. J Thorac Dis. 2016 Oct; 8(10):E1337-E1339. PMID: 27867621.
      Citations:    
    82. Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials. Circ Cardiovasc Interv. 2016 09; 9(9). PMID: 27601429.
      Citations: 14     Fields:    Translation:Humans
    83. Kleiman NS. The Last Detail: Platelets, Glycoprotein IIb/IIIa Antagonists, and Excipients. JACC Cardiovasc Interv. 2016 08 22; 9(16):1677-9. PMID: 27539686.
      Citations:    Fields:    Translation:Cells
    84. Kalra A, Bhatt DL, Pinto DS, Kirtane AJ, Kapadia SR, Makkar RR, Rihal CS, Kleiman NS, Cutlip DE. Accreditation and funding for a 24-month advanced interventional cardiology fellowship program: A call-to-action for optimal training of the next generation of interventionalists. Catheter Cardiovasc Interv. 2016 Nov 15; 88(6):1010-1015. PMID: 27515241.
      Citations: 1     Fields:    Translation:Humans
    85. Reardon MJ, Kleiman NS. Highway to the heart or one more for the road? The continued life of direct aortic access for transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016 12; 152(6):1616-1617. PMID: 27566890.
      Citations:    Fields:    
    86. Kleiman NS. Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance. J Am Coll Cardiol. 2016 07 19; 68(3):294-296. PMID: 27417008.
      Citations: 1     Fields:    Translation:Cells
    87. Ibrahim H, Nadipalli S, Usmani S, DeLao T, Green L, Kleiman NS. Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection. J Thromb Thrombolysis. 2016 Jul; 42(1):77-83. PMID: 26831482.
      Citations: 5     Fields:    Translation:HumansCells
    88. Kleiman NS. VWF, ADAMTS13, and acute coronary syndromes. Blood. 2016 06 09; 127(23):2788-9. PMID: 27282945.
      Citations:    Fields:    Translation:Humans
    89. Skelding KA, Yakubov SJ, Kleiman NS, Reardon MJ, Adams DH, Huang J, Forrest JK, Popma JJ. Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol. 2016 Aug 15; 118(4):560-6. PMID: 27381665.
      Citations: 3     Fields:    Translation:Humans
    90. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jun 07; 67(22):2565-74. PMID: 27050187.
      Citations: 49     Fields:    Translation:Humans
    91. Reardon MJ, Kleiman NS. How Many Roads Lead to Rome? JACC Cardiovasc Interv. 2016 Mar 14; 9(5):481-3. PMID: 26965938.
      Citations:    Fields:    Translation:Humans
    92. Kleiman NS. What Happens in the Cath Lab Stays in the Cath Lab, or Does It?: Intraprocedural Thrombotic Events in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2016 Feb 22; 9(4):338-340. PMID: 26803419.
      Citations:    Fields:    Translation:Humans
    93. Kleiman NS, Reardon MJ. Advances in Transcatheter Aortic Valve Replacement. Methodist Debakey Cardiovasc J. 2016 Jan-Mar; 12(1):33-6. PMID: 27127560.
      Citations:    Fields:    Translation:Humans
    94. Reardon MJ, Kleiman NS. Watching a Procedure Evolve: Sequential Findings From the TVT Registry. Ann Thorac Surg. 2016 Feb; 101(2):417-8. PMID: 26652135.
      Citations:    Fields:    Translation:Humans
    95. Reardon MJ, Kleiman NS. Watching a Procedure Evolve: Sequential Findings From the TVT Registry. J Am Coll Cardiol. 2015 Dec 29; 66(25):2824-2826. PMID: 26652231.
      Citations: 1     Fields:    Translation:Humans
    96. Abu Saleh WK, Tang GH, Ahmad H, Cohen M, Undemir C, Lansman SL, Reyes M, Barker CM, Kleiman NS, Reardon MJ, Ramlawi B. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. Catheter Cardiovasc Interv. 2016 Jul; 88(1):135-43. PMID: 26603266.
      Citations:    Fields:    Translation:Humans
    97. Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging. 2015 Dec; 8(12):1364-1375. PMID: 26508386.
      Citations: 8     Fields:    Translation:Humans
    98. Abu Saleh WK, Goswami R, Al Jabbari O, Barker C, Kleiman NS, Reardon MJ, Ramlawi B. Transcatheter Treatment of Apicoaortic Conduit Dysfunction. J Card Surg. 2015 Dec; 30(12):885-7. PMID: 26440901.
      Citations:    Fields:    Translation:Humans
    99. Yakubov SJ, Adams DH, Watson DR, Reardon MJ, Kleiman NS, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Coselli J, Diez J, Schreiber T, Gleason TG, Conte J, Deeb GM, Huang J, Oh J, Byrne T, Caskey M, Popma JJ. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. J Am Coll Cardiol. 2015 Sep 22; 66(12):1327-34. PMID: 26383718.
      Citations: 10     Fields:    Translation:Humans
    100. Reardon MJ, Kleiman NS. At 5 years, transcatheter aortic valve replacement had similar rates of mortality and stroke as surgical aortic valve replacement in high-risk patients. Evid Based Med. 2015 Dec; 20(6):212-3. PMID: 26296815.
      Citations:    Fields:    Translation:Humans
    101. Chaikriangkrai K, Goswami R, Little S, Chang SM, Ramlawi B, Jhun HY, Kleiman N, Reardon MJ, Barker C. Bioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient. J Card Surg. 2015 Sep; 30(9):697-700. PMID: 26228701.
      Citations: 1     Fields:    Translation:HumansCells
    102. Abu Saleh WK, Goswami R, Chinnadurai P, Al Jabbari O, Barker CM, Lin CH, Kleiman N, Reardon MJ, Ramlawi B. Direct Aortic Access Transcatheter Aortic Valve Replacement: Three-Dimensional Computed Tomography Planning and Real-Time Fluoroscopic Image Guidance. J Heart Valve Dis. 2015 Jul; 24(4):420-5. PMID: 26897809.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    103. Ramlawi B, Abu Saleh WK, Jabbari OA, Barker C, Lin C, Reyes M, Kleiman NS, Reardon MT. Short-Term Outcomes with Direct Aortic Access for Transcatheter Aortic Valve Replacement. J Heart Valve Dis. 2015 Jul; 24(4):426-32. PMID: 26897810.
      Citations: 2     Fields:    Translation:Humans
    104. Kleiman NS, Kolandaivelu K. Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis. J Am Coll Cardiol. 2015 Jun 09; 65(22):2416-9. PMID: 26046735.
      Citations: 1     Fields:    Translation:Humans
    105. Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB, Chetcuti S, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015 Jul 14; 66(2):113-21. PMID: 26055947.
      Citations: 70     Fields:    Translation:Humans
    106. Ibrahim H, Barker CM, Reardon MJ, Kleiman NS. Suicide left ventricle due to conduction disturbance following transcatheter aortic valve replacement and reversal with restoration of sinus rhythm: is there life after death? J Invasive Cardiol. 2015 Jun; 27(6):E107-9. PMID: 26028658.
      Citations:    Fields:    Translation:Humans
    107. Kleiman NS. Is it time to join the cult? Radial access and percutaneous coronary intervention. Circ Cardiovasc Interv. 2015 Jun; 8(6):e002745. PMID: 26056250.
      Citations:    Fields:    Translation:Humans
    108. Goswami R, Colin B, Jackson M, Kleiman N, Little S. Transesophageal echocardiography-guided percutaneous intervention for a mitral valve leaflet perforation. JACC Cardiovasc Interv. 2015 Apr 27; 8(5):754-5. PMID: 25946451.
      Citations: 1     Fields:    Translation:Humans
    109. Osnabrugge RL, Arnold SV, Reynolds MR, Magnuson EA, Wang K, Gaudiani VA, Stoler RC, Burdon TA, Kleiman N, Reardon MJ, Adams DH, Popma JJ, Cohen DJ. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb; 8(2):315-323. PMID: 25700755.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    110. Ibrahim H, Schutt RC, Hannawi B, DeLao T, Barker CM, Kleiman NS. Association of immature platelets with adverse cardiovascular outcomes. J Am Coll Cardiol. 2014 Nov 18-25; 64(20):2122-9. PMID: 25457402.
      Citations: 14     Fields:    Translation:HumansCells
    111. Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Khabbaz K, Tadros P, Zorn GL, Merhi W, Heiser J, Petrossian G, Robinson N, Maini B, Mumtaz M, Lee JS, Gleason TG, Resar J, Conte J, Watson D, Chenoweth S, Popma JJ. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2869-76.e1-7. PMID: 25152474.
      Citations: 3     Fields:    Translation:Humans
    112. Kassi M, Lopez J, Barker C, Trerotola S, Kleiman N, Kurrelmeyer K. Case report: It wasn't cupid: multimodality imaging of inferior vena cava filter fracture with strut migration to the interventricular septum. Methodist Debakey Cardiovasc J. 2014 Jul-Sep; 10(3):198-200. PMID: 25574350.
      Citations: 1     Fields:    Translation:Humans
    113. Pershad A, Fraij G, Massaro JM, David SW, Kleiman NS, Denktas AE, Wilson BH, Dixon SR, Ohman EM, Douglas PS, Moses JW, O'Neill WW. Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64. PMID: 25037676.
      Citations:    Fields:    Translation:Humans
    114. Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta S, Atar D, Suryapranata H, Jensen SE, Forster T, Fernandez-Ortiz A, Schoors D, Radke P, Belli G, Brennan D, Bell G, Krucoff M. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. Eur Heart J. 2014 Oct 01; 35(37):2516-23. PMID: 24796339.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    115. Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circ Cardiovasc Interv. 2014 Jun; 7(3):365-73. PMID: 24736878.
      Citations: 3     Fields:    Translation:Humans
    116. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 08; 370(19):1790-8. PMID: 24678937.
      Citations: 324     Fields:    Translation:Humans
    117. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20; 63(19):1972-81. PMID: 24657695.
      Citations: 134     Fields:    Translation:HumansCTClinical Trials
    118. Kleiman NS. Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation. J Interv Cardiol. 2014 Apr; 27(2):127-30. PMID: 24617441.
      Citations:    Fields:    Translation:Humans
    119. Ramlawi B, Bedeir K, Barker C, Lin CH, Kleiman N, Reardon M. Direct aortic and subclavian access for transcatheter aortic valve replacement: decision making and technique. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):353-6. PMID: 24655905.
      Citations: 1     Fields:    Translation:Humans
    120. Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). Am J Cardiol. 2014 Feb 15; 113(4):621-5. PMID: 24342762.
      Citations: 5     Fields:    Translation:Humans
    121. Cohen MG, Ghatak A, Kleiman NS, Naidu SS, Massaro JM, Kirtane AJ, Moses J, Magnus Ohman E, Džavík V, Palacios IF, Heldman AW, Popma JJ, O'Neill WW. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ?? study. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1057-64. PMID: 24174321.
      Citations: 7     Fields:    Translation:Humans
    122. Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Am Heart J. 2013 Dec; 166(6):1027-34. PMID: 24268217.
      Citations: 2     Fields:    Translation:Humans
    123. Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M, Bruckner B, Orrego CM, Bismuth J, Kleiman NS, Torre-Amione G. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 2013 Oct; 1(5):382-8. PMID: 24621970.
      Citations: 18     Fields:    Translation:Humans
    124. Braun OÖ, Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KJ, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Saucedo JF, Kleiman NS, Varenhorst C. Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thromb Haemost. 2013 Dec; 110(6):1223-31. PMID: 24009042.
      Citations: 7     Fields:    Translation:HumansCells
    125. Chaikriangkrai K, Polsani V, Wei L, Kleiman N, Chang SM. Stenting of a left main coronary artery compressed by a dilated main pulmonary artery. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):E684-7. PMID: 23804497.
      Citations: 2     Fields:    Translation:Humans
    126. Vavalle JP, Clare R, Chiswell K, Rao SV, Petersen JL, Kleiman NS, Mahaffey KW, Wang TY. Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. JACC Cardiovasc Interv. 2013 Jul; 6(7):709-17. PMID: 23866183.
      Citations: 5     Fields:    Translation:Humans
    127. Alam M, Virani SS, Shahzad SA, Siddiqui S, Siddiqui KH, Mumtaz SA, Kleiman NS, Coselli JS, Lakkis NM, Jneid H. Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22. PMID: 23726179.
      Citations: 6     Fields:    Translation:Humans
    128. Gordon PC, Cohen DJ, Kleiman NS, Montgomery JA, Semder CA, Kennedy KF, Keyes MJ, Piana RN. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E356-64. PMID: 22511502.
      Citations:    Fields:    Translation:Humans
    129. Fatemi O, Torguson R, Chen F, Ahmad S, Badr S, Satler LF, Pichard AD, Kleiman NS, Waksman R. Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. Am Heart J. 2013 Jul; 166(1):104-9. PMID: 23816028.
      Citations: 9     Fields:    Translation:HumansCells
    130. Alam M, Bandeali SJ, Kayani WT, Ahmad W, Shahzad SA, Jneid H, Birnbaum Y, Kleiman NS, Coselli JS, Ballantyne CM, Lakkis N, Virani SS. Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol. 2013 Aug 01; 112(3):309-17. PMID: 23642381.
      Citations: 14     Fields:    Translation:Humans
    131. Lopes RD, White JA, Atar D, Keltai M, Kleiman NS, White HD, Widimsky P, Zeymer U, Giugliano RP, Tricoci P, Braunwald E, Bode C, Ohman EM, Armstrong PW, Newby LK. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2013 Oct 03; 168(3):2510-7. PMID: 23578889.
      Citations: 5     Fields:    Translation:Humans
    132. Fatemi O, Paranilam J, Rainow A, Kennedy K, Choi J, Cutlip D, Pencina M, Berger PB, Cohen DJ, Kleiman NS. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2013 Jan; 35(1):57-64. PMID: 22752404.
      Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
    133. Alam M, Huang HD, Shahzad SA, Kar B, Virani SS, Rogers PA, Paniagua D, Bozkurt B, Palacios I, Kleiman NS, Jneid H. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82. PMID: 23123552.
      Citations: 10     Fields:    Translation:Humans
    134. Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, Cutlip DE, Kleiman NS. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012 Dec; 5(6):772-82. PMID: 23093553.
      Citations: 6     Fields:    Translation:Humans
    135. O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012 Oct 02; 126(14):1717-27. PMID: 22935569.
      Citations: 92     Fields:    Translation:Humans
    136. Alviar CL, Tellez A, Wang M, Potts P, Smith D, Tsui M, Budzynski W, Raizner AE, Kleiman NS, Lev EI, Granada JF, Kaluza GL. Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis. 2012 Jul; 34(1):91-8. PMID: 22350685.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    137. Caputo RP, Goel A, Pencina M, Cohen DJ, Kleiman NS, Yen CH, Waksman R, Tolerico P, Dhar G, Gordon P, Bach RG, Lopez JJ. Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). Am J Cardiol. 2012 Aug 01; 110(3):350-5. PMID: 22560770.
      Citations: 9     Fields:    Translation:Humans
    138. Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Catheter Cardiovasc Interv. 2012 Dec 01; 80(7):1127-36. PMID: 22431166.
      Citations:    Fields:    Translation:Humans
    139. Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, Dixon S, Rihal C, Dave R, O'Neill W. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):717-25. PMID: 22105829.
      Citations: 14     Fields:    Translation:Humans
    140. Alam M, Bandeali SJ, Virani SS, Jneid HM, Shahzad SA, Ramanathan KB, Kar B, Kleiman NS, Lakkis N. Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6. PMID: 22488047.
      Citations: 2     Fields:    Translation:Humans
    141. Kleiman N. Introduction to transcatheter aortic valve implantation. Methodist Debakey Cardiovasc J. 2012 Apr-Jun; 8(2):2-3. PMID: 22891119.
      Citations:    Fields:    Translation:Humans
    142. Kleiman N. Room considerations with TAVR. Methodist Debakey Cardiovasc J. 2012 Apr-Jun; 8(2):19-21. PMID: 22891123.
      Citations: 1     Fields:    Translation:Humans
    143. Kleiman NS. Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation. Circulation. 2012 Apr 24; 125(16):1967-70. PMID: 22438531.
      Citations: 3     Fields:    Translation:Humans
    144. Novack V, Pencina M, Cohen DJ, Kleiman NS, Yen CH, Saucedo JF, Berger PB, Cutlip DE. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med. 2012 Mar 26; 172(6):502-8. PMID: 22371874.
      Citations: 20     Fields:    Translation:Humans
    145. Ibrahim H, Nadipalli S, DeLao T, Guthikonda S, Kleiman NS. Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis. 2012 Feb; 33(2):137-42. PMID: 22198802.
      Citations: 15     Fields:    Translation:HumansCells
    146. Win HK, Polsani V, Chang SM, Kleiman NS. Stent-assisted coil embolization of a large fusiform aneurysm of proximal anterior descending artery: novel treatment for coronary aneurysms. Circ Cardiovasc Interv. 2012 Feb 01; 5(1):e3-5. PMID: 22338006.
      Citations: 4     Fields:    Translation:Humans
    147. Stolker JM, Cohen DJ, Lindsey JB, Kennedy KF, Kleiman NS, Marso SP. Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry. Am Heart J. 2011 Nov; 162(5):914-21. PMID: 22093209.
      Citations: 2     Fields:    Translation:Humans
    148. Venkitachalam L, Lei Y, Magnuson EA, Chan PS, Stolker JM, Kennedy KF, Kleiman NS, Cohen DJ. Survival benefit with drug-eluting stents in observational studies: fact or artifact? Circ Cardiovasc Qual Outcomes. 2011 Nov 01; 4(6):587-94. PMID: 21988921.
      Citations: 7     Fields:    Translation:Humans
    149. Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):474-80. PMID: 21972402.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    150. Buergler JM, Kleiman NS. Balancing hemostasis and thrombosis in interventional vascular medicine and surgery. Methodist Debakey Cardiovasc J. 2011 Oct-Dec; 7(4):19-23. PMID: 22143472.
      Citations:    Fields:    Translation:Humans
    151. Bangalore S, Cohen DJ, Kleiman NS, Regev-Beinart T, Rao SV, Pencina MJ, Mauri L. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):463-73. PMID: 21972401.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    152. Kleiman NS. Bringing it all together: integration of physiology with anatomy during cardiac catheterization. J Am Coll Cardiol. 2011 Sep 13; 58(12):1219-21. PMID: 21903053.
      Citations: 10     Fields:    Translation:Humans
    153. Venkitachalam L, Lei Y, Stolker JM, Mahoney EM, Amin AP, Lindsey JB, Kennedy KF, Pencina MJ, Lopez JJ, Kleiman NS, Cohen DJ. Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation. 2011 Aug 30; 124(9):1028-37. PMID: 21844081.
      Citations: 8     Fields:    Translation:Humans
    154. French JK, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Hellkamp AS, Stebbins A, Holmes DR, Hochman JS, Granger CB, Mahaffey KW. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". Am Heart J. 2011 Jul; 162(1):89-97. PMID: 21742094.
      Citations: 3     Fields:    Translation:Humans
    155. Amin AP, Kennedy KF, Pencina M, Berger P, Piana RN, Lopez J, Kleiman N, Cohen DJ. Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol. 2011 Jun 15; 107(12):1751-6. PMID: 21640216.
      Citations: 2     Fields:    Translation:Humans
    156. Rodriguez G, Starr AZ, Czernuszewicz GZ, Manhas A, Alhariri A, Willerson JT, Reist CJ, Pieper K, Mahaffey KW, Marian AJ, Kleiman NS. Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest. 2011 Dec; 41(12):1299-309. PMID: 21615392.
      Citations: 3     Fields:    Translation:Humans
    157. Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ. The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circ Cardiovasc Qual Outcomes. 2011 Mar; 4(2):211-9. PMID: 21304094.
      Citations: 1     Fields:    Translation:Humans
    158. Brilakis ES, Cohen DJ, Kleiman NS, Pencina M, Nassif D, Saucedo J, Piana RN, Banerjee S, Keyes MJ, Yen CH, Berger PB. Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J. 2011 Feb; 161(2):360-6. PMID: 21315220.
      Citations: 5     Fields:    Translation:Humans
    159. Becker RC, Mahaffey KW, Yang H, Marian AJ, Furman MI, Michael Lincoff A, Hazen SL, Petersen JL, Reist CJ, Kleiman NS. Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome. J Thromb Thrombolysis. 2011 Feb; 31(2):146-53. PMID: 21086021.
      Citations: 2     Fields:    Translation:HumansCells
    160. Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW. Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Contemp Clin Trials. 2011 Mar; 32(2):178-87. PMID: 21220052.
      Citations: 3     Fields:    Translation:Humans
    161. Kleiman N, Reardon MJ. TAVI: transcatheter aortic valve implantation. Methodist Debakey Cardiovasc J. 2011 Jan-Mar; 7(1):49-52. PMID: 21490555.
      Citations:    Fields:    Translation:Humans
    162. Giugliano RP, Pollack CV, Brogan GX, Cohen M, Diercks DB, Grines CL, Henry TD, Kleiman NS. Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtable discussion. J Interv Cardiol. 2011 Apr; 24(2):119-36. PMID: 21114529.
      Citations:    Fields:    Translation:Humans
    163. Mangalpally KK, Kleiman NS. The safety of clopidogrel. Expert Opin Drug Saf. 2011 Jan; 10(1):85-95. PMID: 21091040.
      Citations: 2     Fields:    Translation:Humans
    164. Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis. 2010 Oct; 30(3):251-62. PMID: 20502945.
      Citations: 17     Fields:    Translation:HumansCells
    165. Lopez JJ, Keyes MJ, Nathan S, Piana R, Pencina M, Dhar G, Marso S, Rao S, Shammo S, Marquardt W, Cohen DJ, Kleiman NS. Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J. 2010 Oct; 160(4):767-74. PMID: 20934573.
      Citations: 2     Fields:    Translation:Humans
    166. Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, Sonel A, Browne K, Barseness G, Cohen DJ. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010 Sep; 3(9):920-7. PMID: 20850090.
      Citations: 22     Fields:    Translation:Humans
    167. Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug; 3(4):327-34. PMID: 20606136.
      Citations: 15     Fields:    Translation:Humans
    168. Kleiman NS. PLATO study of ticagrelor versus clopidogrel in patients with high-risk acute coronary syndromes. Curr Cardiol Rep. 2010 Jul; 12(4):283-5. PMID: 20432073.
      Citations:    Fields:    
    169. Cohen M, Levine GN, Pieper KS, Lan L, Antman EM, Aylward PE, White HD, Kleiman NS, Califf RM, Mahaffey KW. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35. PMID: 20432399.
      Citations: 3     Fields:    Translation:Humans
    170. Kleiman NS. Resistance or resistors? Has Ohm's law come to antiplatelet therapy? Am Heart J. 2010 May; 159(5):713-5. PMID: 20435177.
      Citations:    Fields:    Translation:Humans
    171. Rao SV, Melloni C, Myles-Dimauro S, Broderick S, Kosinski AS, Kleiman NS, Dzavík V, Tanguay JF, Chandna H, Gammon R, Rivera E, Alexander JH, Fier I, Roach J, Becker RC. Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. Circulation. 2010 Apr 20; 121(15):1713-21. PMID: 20368520.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    172. Lev EI, Solodky A, Harel N, Mager A, Brosh D, Assali A, Roller M, Battler A, Kleiman NS, Kornowski R. Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol. 2010 Jan 12; 55(2):114-21. PMID: 20117379.
      Citations: 24     Fields:    Translation:Humans
    173. Granada JF, Alviar CL, Wallace-Bradley D, Osteen M, Dave B, Tellez A, Win HK, Kleiman NS, Kaluza GL, Lev EI. Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. J Thromb Thrombolysis. 2010 Jan; 29(1):60-9. PMID: 19466381.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    174. Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL. Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med. 2009 Dec 10; 361(24):2318-29. PMID: 19915221.
      Citations: 88     Fields:    Translation:Humans
    175. Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 2009 Dec 10; 361(24):2330-41. PMID: 19915222.
      Citations: 96     Fields:    Translation:Humans
    176. Putney DR, Kleiman NS, Fromm RE, Buergler JM. Impact of computerized dosing on eptifibatide-associated bleeding and mortality. Am Heart J. 2009 Dec; 158(6):1018-23. PMID: 19958870.
      Citations:    Fields:    Translation:Humans
    177. Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv. 2009 Nov; 2(11):1074-82. PMID: 19926047.
      Citations: 17     Fields:    Translation:Humans
    178. Novack V, Cutlip D, Kleiman N, Pencina M, Mauri L, Yen CH, Berger P, Goldberg S, Kellett M, Waksman R, Hong M, Raizner AE, Cohen DJ. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75. PMID: 19695546.
      Citations:    Fields:    Translation:Humans
    179. Holmes DR, Kereiakes DJ, Kleiman NS, Moliterno DJ, Patti G, Grines CL. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol. 2009 Jul 07; 54(2):95-109. PMID: 19573725.
      Citations: 22     Fields:    Translation:Humans
    180. Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):874-80. PMID: 19180665.
      Citations: 1     Fields:    Translation:Humans
    181. Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol. 2009 Jul 15; 104(2):227-33. PMID: 19576352.
      Citations: 22     Fields:    Translation:HumansCells
    182. Little SH, Kleiman N, Guthikonda S. Percutaneous paravalvular repair: guidance using live 3-dimensional transesophageal echocardiography. J Am Coll Cardiol. 2009 Apr 21; 53(16):1467. PMID: 19371832.
      Citations: 1     Fields:    Translation:Humans
    183. Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, Kleiman NS, Brindis RG, Peacock WF, Brener SJ, Menon V, Smith SC, Pollack CV, Gibler WB, Ohman EM, Roe MT. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J. 2009 May; 30(10):1195-202. PMID: 19339264.
      Citations: 20     Fields:    Translation:Humans
    184. Crespo EM, Oliveira GB, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, Ohman EM. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J. 2009 Apr; 157(4):651-7. PMID: 19332191.
      Citations: 7     Fields:    Translation:Humans
    185. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, Moliterno DJ, Nassif D, Lopez JJ, Saucedo JF. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Jan; 2(1):37-45. PMID: 19463396.
      Citations: 37     Fields:    Translation:Humans
    186. Kleiman NS. Searching for the ceiling: new reflections on the disposition and metabolism of clopidogrel. JACC Cardiovasc Interv. 2008 Dec; 1(6):628-30. PMID: 19463376.
      Citations:    Fields:    Translation:HumansCells
    187. Kleiman NS. Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician? J Am Coll Cardiol. 2008 Nov 04; 52(19):1564-6. PMID: 19007593.
      Citations: 1     Fields:    Translation:Humans
    188. Little SH, Zekry SB, Zoghbi WA, Kleiman NS, Guthikonda S. Three-dimensional transesophageal echocardiogram provides real-time guidance during percutaneous paravalvular mitral repair. Circ Heart Fail. 2008 Nov; 1(4):293-4. PMID: 19808306.
      Citations:    Fields:    Translation:Humans
    189. Vaduganathan M, Alviar CL, Arikan ME, Tellez A, Guthikonda S, DeLao T, Granada JF, Kleiman NS, Ballantyne CM, Lev EI. Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J. 2008 Nov; 156(5):1002.e1-1002.e7. PMID: 19061719.
      Citations: 16     Fields:    Translation:HumansCells
    190. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol. 2008 Aug 26; 52(9):743-9. PMID: 18718422.
      Citations: 62     Fields:    Translation:Humans
    191. Garg R, Tellez A, Alviar C, Granada J, Kleiman NS, Lev EI. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Catheter Cardiovasc Interv. 2008 Aug 01; 72(2):205-9. PMID: 18651648.
      Citations: 8     Fields:    Translation:HumansCells
    192. Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008 Aug 05; 118(6):632-8. PMID: 18645057.
      Citations: 11     Fields:    Translation:Humans
    193. Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Thromb Haemost. 2008 Jul; 100(1):83-9. PMID: 18612542.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    194. Kleiman NS. Should Prasugrel or Clopidogrel Be Used in Patients with ACS? Curr Cardiol Rep. 2008 Jul; 10(4):301-2. PMID: 18611364.
      Citations:    Fields:    
    195. Kleiman NS, Freedman JE, Tracy PB, Furie BC, Bray PF, Rao SV, Phillips DR, Storey RF, Rusconi CP, French PA, Steinhubl SR, Becker RC. Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development. Platelets. 2008 Jun; 19(4):239-51. PMID: 18569859.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    196. Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation. 2008 Jun 03; 117(22):2865-74. PMID: 18506005.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    197. Kleiman NS. Will measuring vasodilator-stimulated phosphoprotein phosphorylation help us optimize the loading dose of clopidogrel? J Am Coll Cardiol. 2008 Apr 08; 51(14):1412-4. PMID: 18387445.
      Citations:    Fields:    Translation:HumansCells
    198. Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Feb 19; 117(7):886-96. PMID: 18250271.
      Citations: 54     Fields:    Translation:Humans
    199. Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008 Mar; 23(3):310-6. PMID: 18196350.
      Citations: 5     Fields:    Translation:Humans
    200. Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008 Jan 14; 168(1):94-102. PMID: 18195201.
      Citations: 20     Fields:    Translation:HumansCells
    201. Buergler JM, Alam S, Spencer W, Kleiman NS, Melendez Y, Franklin J, Nagueh SF. Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec; 20(6):559-63. PMID: 18042061.
      Citations:    Fields:    Translation:Humans
    202. Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 2007 Dec 04; 116(23):2669-77. PMID: 18025532.
      Citations: 11     Fields:    Translation:Humans
    203. Lev EI, Arikan ME, Vaduganathan M, Alviar CL, Tellez A, Mathuria N, Builes A, Granada JF, del Conde I, Kleiman NS. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease. Am Heart J. 2007 Oct; 154(4):694.e1-7. PMID: 17892993.
      Citations: 5     Fields:    Translation:Humans
    204. Patel RT, Lev EI, Vaduganathan M, Guthikonda S, Bergeron A, Maresh K, Dong JF, Kleiman NS. Platelet reactivity among Asian Indians and Caucasians. Platelets. 2007 Jun; 18(4):261-5. PMID: 17538846.
      Citations: 3     Fields:    Translation:HumansCells
    205. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007 May 09; 297(18):2001-9. PMID: 17488965.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    206. Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May; 153(5):874-80. PMID: 17452167.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    207. Dzavík V, Cotter G, Reynolds HR, Alexander JH, Ramanathan K, Stebbins AL, Hathaway D, Farkouh ME, Ohman EM, Baran DA, Prondzinsky R, Panza JA, Cantor WJ, Vered Z, Buller CE, Kleiman NS, Webb JG, Holmes DR, Parrillo JE, Hazen SL, Gross SS, Harrington RA, Hochman JS. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J. 2007 May; 28(9):1109-16. PMID: 17459901.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    208. Lev EI, Ramchandani M, Garg R, Wojciechowski Z, Builes A, Vaduganathan M, Tripathy U, Kleiman NS. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis. 2007 Aug; 24(1):15-21. PMID: 17277998.
      Citations:    Fields:    Translation:Humans
    209. Schweiger MJ, Chambers CE, Davidson CJ, Zhang S, Blankenship J, Bhalla NP, Block PC, Dervan JP, Gasperetti C, Gerber L, Kleiman NS, Krone RJ, Phillips WJ, Siegel RM, Uretsky BF, Laskey WK. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007 Jan; 69(1):135-40. PMID: 17139671.
      Citations: 27     Fields:    Translation:Humans
    210. Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SG. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv. 2007 Jan; 69(1):73-83. PMID: 17139670.
      Citations: 11     Fields:    Translation:Humans
    211. Lev EI, Alviar CL, Arikan ME, Dave BP, Granada JF, DeLao T, Tellez A, Maresh K, Kleiman NS. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Am Heart J. 2007 Jan; 153(1):41.e1-6. PMID: 17174635.
      Citations: 3     Fields:    Translation:Humans
    212. White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ, Califf RM. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. Am Heart J. 2006 Dec; 152(6):1042-50. PMID: 17161049.
      Citations: 14     Fields:    Translation:Humans
    213. Lev EI, Ramabadran RS, Guthikonda S, Patel R, Kleiman A, Granada JF, DeLao T, Kleiman NS. Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects. Am J Cardiol. 2007 Jan 01; 99(1):124-8. PMID: 17196475.
      Citations: 2     Fields:    Translation:HumansCells
    214. Kleiman NS. Measuring troponin elevation after percutaneous coronary intervention: ready for prime time? J Am Coll Cardiol. 2006 Nov 07; 48(9):1771-3. PMID: 17084248.
      Citations: 1     Fields:    Translation:Humans
    215. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006 Oct; 152(4):641-7. PMID: 16996828.
      Citations: 32     Fields:    Translation:Humans
    216. Lev EI, Estrov Z, Aboulfatova K, Harris D, Granada JF, Alviar C, Kleiman NS, Dong JF. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thromb Haemost. 2006 Oct; 96(4):498-504. PMID: 17003929.
      Citations: 21     Fields:    Translation:HumansCells
    217. Exaire JE, Butman SM, Ebrahimi R, Kleiman NS, Harrington RA, Schweiger MJ, Bittl JA, Wolski K, Topol EJ, Lincoff AM. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Am Heart J. 2006 Jul; 152(1):157-63. PMID: 16824849.
      Citations: 2     Fields:    Translation:Humans
    218. Rajagopal V, Lincoff AM, Cohen DJ, Gurm HS, Hu T, Desmet WJ, Kleiman NS, Bittl JA, Feit F, Topol EJ. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Am Heart J. 2006 Jul; 152(1):149-54. PMID: 16824845.
      Citations: 4     Fields:    Translation:Humans
    219. Lev EI, Tayyan N, Raizner AE, Solomon SL, Simmons D, Kleiman NS. Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coron Artery Dis. 2006 May; 17(4):379-84. PMID: 16707962.
      Citations: 1     Fields:    Translation:Humans
    220. Blankenship JC, Haldis T, Feit F, Hu T, Kleiman NS, Topol EJ, Lincoff AM. Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). Am J Cardiol. 2006 Jun 01; 97(11):1591-6. PMID: 16728220.
      Citations: 4     Fields:    Translation:Humans
    221. Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res. 2007; 119(3):355-60. PMID: 16581111.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    222. Lev EI, Patel R, Karim A, Kleiman A, Badimon JJ, Kleiman NS. Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. Thromb Haemost. 2006 Mar; 95(3):441-6. PMID: 16525571.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    223. Ellis TC, Lev E, Yazbek NF, Kleiman NS. Therapeutic strategies for cardiogenic shock, 2006. Curr Treat Options Cardiovasc Med. 2006 Feb; 8(1):79-94. PMID: 16401386.
      Citations:    
    224. Atmakuri SR, Lev EI, Alviar C, Ibarra E, Raizner AE, Solomon SL, Kleiman NS. Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions. J Am Coll Cardiol. 2006 Feb 07; 47(3):515-21. PMID: 16458129.
      Citations: 4     Fields:    Translation:Humans
    225. Guthikonda S, Kleiman NS. Is aspirin resistance valid? Future Cardiol. 2006 Jan; 2(1):1-4. PMID: 19804124.
      Citations:    Fields:    
    226. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006 Jan 03; 47(1):27-33. PMID: 16386660.
      Citations: 68     Fields:    Translation:Humans
    227. Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA. 2005 Nov 23; 294(20):2594-600. PMID: 16304073.
      Citations: 11     Fields:    Translation:Humans
    228. Jacob S, Cohen DJ, Massaro J, Niemyski P, Maresh K, Kleiman N. Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J. 2005 Nov; 150(5):887-92. PMID: 16290954.
      Citations: 1     Fields:    Translation:Humans
    229. Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z. Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J Vasc Res. 2005 Sep-Oct; 42(5):408-14. PMID: 16088214.
      Citations: 16     Fields:    Translation:HumansCells
    230. Guthikonda S, Lev EI, Kleiman NS. Resistance to antiplatelet therapy. Curr Cardiol Rep. 2005 Jul; 7(4):242-8. PMID: 15987620.
      Citations: 2     Fields:    Translation:HumansCells
    231. Kleiman NS. Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide? Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):344-5. PMID: 16265559.
      Citations:    Fields:    Translation:HumansPHPublic Health
    232. Gurm HS, Sarembock IJ, Kereiakes DJ, Young JJ, Harrington RA, Kleiman N, Feit F, Wolski K, Bittl JA, Wilcox R, Topol EJ, Lincoff AM. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. J Am Coll Cardiol. 2005 Jun 21; 45(12):1932-8. PMID: 15963389.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    233. Mahaffey KW, Roe MT, Kilaru R, French JK, Alexander JH, Berdan LG, Van De Werf F, Simoons ML, Weaver WD, White HD, Lincoff AM, Kleiman NS, Topol EJ, Harrington RA. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. Am J Cardiol. 2005 Jun 15; 95(12):1404-8. PMID: 15950560.
      Citations: 2     Fields:    Translation:Humans
    234. Buergler JM, Maliszewski CR, Broekman MJ, Kaluza GL, Schulz DG, Marcus AJ, Raizner AE, Kleiman NS, Ali NM. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model. J Thromb Thrombolysis. 2005 Apr; 19(2):115-22. PMID: 16052302.
      Citations: 10     Fields:    Translation:HumansAnimals
    235. Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, Moliterno DJ. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv. 2005 Mar; 64(3):369-72. PMID: 15736260.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    236. del Conde I, Nabi F, Tonda R, Thiagarajan P, López JA, Kleiman NS. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1065-70. PMID: 15705928.
      Citations: 16     Fields:    Translation:HumansCells
    237. Ohman EM, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005 Feb; 19(1):11-9. PMID: 15976962.
      Citations: 3     Fields:    Translation:Humans
    238. Prahash A, Kleiman N, Espada R, Dokainish H. Idiopathic sinus of Valsalva to right atrial fistula: an unusual origin of right-sided heart failure. J Am Soc Echocardiogr. 2004 Dec; 17(12):1317-8. PMID: 15562275.
      Citations: 1     Fields:    Translation:Humans
    239. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC, Pollack CV, Gibler WB, Ohman EM. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004 Nov 03; 292(17):2096-104. PMID: 15523070.
      Citations: 77     Fields:    Translation:Humans
    240. Cox DS, Kleiman NS, Boyle DA, Aluri J, Parchman LG, Holdbrook F, Fossler MJ. Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention. J Clin Pharmacol. 2004 Sep; 44(9):981-90. PMID: 15317826.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    241. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA. 2004 Aug 11; 292(6):696-703. PMID: 15304466.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    242. Petersen JL, Mahaffey KW, Becker RC, Goodman SG, Kleiman NS, Marian AJ, Stone GW, Lansky AJ, Lincoff AM, Hazen SL, Nessel CC, Toro-Figueroa L, Tate L, Reist CJ, Cohen M, Califf RM, Ferguson JJ. Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library. Am Heart J. 2004 Aug; 148(2):269-76. PMID: 15308996.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    243. Jang IK, Lewis BE, Matthai WH, Kleiman NS. Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study. J Thromb Thrombolysis. 2004 Aug; 18(1):31-7. PMID: 15744551.
      Citations: 10     Fields:    Translation:Humans
    244. Rajagopal V, Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, Jia G, Topol EJ. Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol. 2004 Jul 15; 94(2):190-2. PMID: 15246898.
      Citations: 4     Fields:    Translation:Humans
    245. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004 Jul 07; 292(1):45-54. PMID: 15238590.
      Citations: 108     Fields:    Translation:HumansCTClinical Trials
    246. Chang WC, Boersma E, Granger CB, Harrington RA, Califf RM, Simoons ML, Kleiman NS, Armstrong PW. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J. 2004 Jul; 148(1):62-71. PMID: 15215793.
      Citations: 7     Fields:    Translation:Humans
    247. Kleiman NS. Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation. J Am Coll Cardiol. 2004 Jun 02; 43(11):1989-91. PMID: 15172402.
      Citations:    Fields:    Translation:HumansCells
    248. Dakik HA, Koubeissi Z, Kleiman NS, Nasrallah A, Sawaya J, Gharzuddine W, Tamim H, Shaar K, Alam S. Acute myocardial infarction: clinical characteristics, management and outcome in a university medical centre in a developing Middle Eastern country. Can J Cardiol. 2004 Jun; 20(8):789-93. PMID: 15229760.
      Citations: 4     Fields:    Translation:Humans
    249. Labinaz M, Kaul P, Harrington RA, Chang WC, Kleiman NS, Simoons ML, Boersma E, Akkerhuis KM, Califf RM, Armstrong PW. Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. Can J Cardiol. 2004 Jun; 20(8):773-8. PMID: 15229770.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    250. Lincoff AM, Bittl JA, Kleiman NS, Sarembock IJ, Jackman JD, Mehta S, Tannenbaum MA, Niederman AL, Bachinsky WB, Tift-Mann J, Parker HG, Kereiakes DJ, Harrington RA, Feit F, Maierson ES, Chew DP, Topol EJ. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol. 2004 May 01; 93(9):1092-6. PMID: 15110198.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    251. Quinn MJ, Aronow HD, Califf RM, Bhatt DL, Sapp S, Kleiman NS, Harrington RA, Kong DF, Kandzari DE, Topol EJ. Aspirin dose and six-month outcome after an acute coronary syndrome. J Am Coll Cardiol. 2004 Mar 17; 43(6):972-8. PMID: 15028352.
      Citations: 3     Fields:    Translation:Humans
    252. Pieper KS, Tsiatis AA, Davidian M, Hasselblad V, Kleiman NS, Boersma E, Chang WC, Griffin J, Armstrong PW, Califf RM, Harrington RA. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. Circulation. 2004 Feb 10; 109(5):641-6. PMID: 14769687.
      Citations: 6     Fields:    Translation:Humans
    253. Conde ID, Kleiman NS. Patient-specific antiplatelet therapy. J Thromb Thrombolysis. 2004 Feb; 17(1):63-77. PMID: 15277789.
      Citations:    Fields:    Translation:Humans
    254. Yazbek NF, Kleiman NS. Therapeutic Strategies for Cardiogenic Shock. Curr Treat Options Cardiovasc Med. 2004 Feb; 6(1):29-41. PMID: 15023282.
      Citations:    
    255. Urquidi-Macdonald M, Mager DE, Mascelli MA, Frederick B, Freedman J, Fitzgerald DJ, Kleiman NS, Abernethy DR. Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability. Clin Pharmacol Ther. 2004 Jan; 75(1):60-9. PMID: 14749692.
      Citations: 1     Fields:    Translation:Humans
    256. Granada JF, Kleiman NS. Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting. Am J Cardiovasc Drugs. 2004; 4(1):31-41. PMID: 14967064.
      Citations: 3     Fields:    Translation:Humans
    257. Kleiman NS, Patel NC, Allen KB, Simons M, Ylä-Herttuala S, Griffin E, Dzau VJ. Evolving revascularization approaches for myocardial ischemia. Am J Cardiol. 2003 Nov 07; 92(9B):9N-17N. PMID: 14615021.
      Citations: 4     Fields:    Translation:HumansAnimals
    258. Grines C, Rubanyi GM, Kleiman NS, Marrott P, Watkins MW. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol. 2003 Nov 07; 92(9B):24N-31N. PMID: 14615023.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    259. Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C, Kleiman N. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003 Oct 15; 42(8):1339-47. PMID: 14563572.
      Citations: 47     Fields:    Translation:HumansCellsCTClinical Trials
    260. Mager DE, Mascelli MA, Kleiman NS, Fitzgerald DJ, Abernethy DR. Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty. J Pharmacol Exp Ther. 2003 Dec; 307(3):969-76. PMID: 14534354.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    261. Conde ID, Kleiman NS. Arterial thrombosis for the interventional cardiologist: from adhesion molecules and coagulation factors to clinical therapeutics. Catheter Cardiovasc Interv. 2003 Oct; 60(2):236-46. PMID: 14517933.
      Citations: 3     Fields:    Translation:Humans
    262. Moliterno DJ, Hermiller JB, Kereiakes DJ, Yow E, Applegate RJ, Braden GA, Dippel EJ, Furman MI, Grines CL, Kleiman NS, Levine GN, Mann T, Nair RN, Stine RA, Yacubov SJ, Tcheng JE. A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9. PMID: 13678943.
      Citations: 7     Fields:    Translation:Humans
    263. Becker R, Butenas S, Carr M, Jaffer F, Kleiman NS, Marmur JD, Schneider DJ, Spiess BD, Steinhubl SR, Weitz JI. Bivalirudin, thrombin and platelets: clinical implications and future directions. J Invasive Cardiol. 2003 Aug; Suppl:2-15. PMID: 23570139.
      Citations:    Fields:    Translation:HumansAnimalsCells
    264. Yazbek N, Bapat A, Kleiman N. Platelet abnormalities in diabetes mellitus. Coron Artery Dis. 2003 Aug; 14(5):365-71. PMID: 12878901.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    265. Conde ID, Kleiman NS. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003 Jun 19; 348(25):2575-7; author reply 2575-7. PMID: 12816111.
      Citations: 4     Fields:    Translation:Humans
    266. Kleiman NS. Combination therapy for acute myocardial infarction: will it survive? J Am Coll Cardiol. 2003 Apr 16; 41(8):1261-3. PMID: 12706918.
      Citations:    Fields:    Translation:HumansAnimals
    267. Nguyen-Ho P, Kleiman NS, Verani MS. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Can J Cardiol. 2003 Mar 15; 19(3):300-2. PMID: 12677287.
      Citations: 1     Fields:    Translation:Humans
    268. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003 Feb 19; 289(7):853-63. PMID: 12588269.
      Citations: 148     Fields:    Translation:HumansCTClinical Trials
    269. Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, Ballantyne C, McIntire LV, O'Brian Smith E, Klem JA, Mathew S, Frangogiannis N, Turner NA, Maresh KJ, Kleiman NS. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res. 2003; 111(3):171-7. PMID: 14678816.
      Citations: 12     Fields:    Translation:HumansCells
    270. Kereiakes DJ, Montalescot G, Antman EM, Cohen M, Darius H, Ferguson JJ, Grines C, Karsch KR, Kleiman NS, Moliterno DJ, Steg PG, Teirstein P, Van de Werf F, Wallentin L. Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J. 2002 Oct; 144(4):615-24. PMID: 12360156.
      Citations: 4     Fields:    Translation:Humans
    271. Fernandes LS, Tcheng JE, O'Shea JC, Weiner B, Lorenz TJ, Pacchiana C, Berdan LG, Maresh KJ, Joseph D, Madan M, Mann T, Kilaru R, Hochman JS, Kleiman NS. Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study. J Am Coll Cardiol. 2002 Sep 18; 40(6):1085-91. PMID: 12354432.
      Citations: 6     Fields:    Translation:Humans
    272. Kleiman NS, Lakkis N, Cannon CP, Murphy SA, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2002 Sep 18; 40(6):1044-50. PMID: 12354426.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    273. Topol EJ, Lincoff AM, Kereiakes DJ, Kleiman NS, Cohen EA, Ferguson JJ, Tcheng JE, Sapp S, Califf RM. Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. Am J Med. 2002 Jul; 113(1):1-6. PMID: 12106616.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    274. Dyke CK, Becker RC, Kleiman NS, Hochman JS, Bovill EG, Lincoff AM, Gerstenblith G, Dzavik V, Gardner LH, Hasselblad V, Zillman LA, Shimoto Y, Robertson TL, Kunitada S, Armstrong PW, Harrington RA. First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Circulation. 2002 May 21; 105(20):2385-91. PMID: 12021225.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    275. Lincoff AM, Kleiman NS, Kottke-Marchant K, Maierson ES, Maresh K, Wolski KE, Topol EJ. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am Heart J. 2002 May; 143(5):847-53. PMID: 12040347.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    276. Kleiman NS. Antiplatelet therapy and coronary interventions: childhood friends or permanent partners? J Interv Cardiol. 2002 Apr; 15(2):111-3. PMID: 12063805.
      Citations:    Fields:    Translation:Humans
    277. Kleiman NS, Klem J, Fernandes LS, Rubin H, Challa S, Solomon S, Maresh K, Arora U, Klem E, Buergler J, Mathew S, Browning A, DeLao T. Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. Am Heart J. 2002 Apr; 143(4):585-93. PMID: 11923794.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    278. Arora UK, Conde I, Kleiman NS. Glycoprotein IIb/IIIa antagonists in the setting of rescue percutaneous coronary intervention. J Interv Cardiol. 2002 Apr; 15(2):155-62. PMID: 12063811.
      Citations:    Fields:    Translation:Humans
    279. Mazur W, Kaluza GL, Sapp S, Balog C, Topol EJ, Mark DB, Ellis SG, Kereiakes DJ, Lincoff AM, Kleiman NS. Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. Am Heart J. 2002 Apr; 143(4):594-601. PMID: 11923795.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    280. Abernethy DR, Pezzullo J, Mascelli MA, Frederick B, Kleiman NS, Freedman J. Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects. Clin Pharmacol Ther. 2002 Mar; 71(3):186-95. PMID: 11907493.
      Citations: 6     Fields:    Translation:Humans
    281. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002 Feb 19; 105(7):788-93. PMID: 11854116.
      Citations: 143     Fields:    Translation:HumansCTClinical Trials
    282. O'Shea JC, Buller CE, Cantor WJ, Chandler AB, Cohen EA, Cohen DJ, Gilchrist IC, Kleiman NS, Labinaz M, Madan M, Hafley GE, Califf RM, Kitt MM, Strony J, Tcheng JE. Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. JAMA. 2002 Feb 06; 287(5):618-21. PMID: 11829701.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    283. Mahaffey KW, Roe MT, Dyke CK, Newby LK, Kleiman NS, Connolly P, Berdan LG, Sparapani R, Lee KL, Armstrong PW, Topol EJ, Califf RM, Harrington RA. Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial. Am Heart J. 2002 Feb; 143(2):242-8. PMID: 11835026.
      Citations: 10     Fields:    Translation:Humans
    284. Kleiman NS. Antiplatelet therapy and coronary interventions: childhood friends or permanent partners? J Interv Cardiol. 2002 Feb; 15(1):41-3. PMID: 12053683.
      Citations:    Fields:    Translation:Humans
    285. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Curr Control Trials Cardiovasc Med. 2001 Jul 17; 2(4):187-194. PMID: 11806794.
      Citations:    
    286. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM. Systematic adjudication of myocardial infarction end-points in an international clinical trial. Curr Control Trials Cardiovasc Med. 2001 Jul 17; 2(4):180-186. PMID: 11806793.
      Citations:    
    KLEIMAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (623)
    Explore
    _
    Co-Authors (31)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _